Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) saw a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 1,032 shares, a drop of 95.3% from the April 15th total of 21,996 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 19,994 shares, the short-interest ratio is presently 0.1 days.
Raia Drogasil Price Performance
RADLY traded down $0.12 on Monday, hitting $4.25. The company had a trading volume of 21,079 shares, compared to its average volume of 18,148. The stock has a fifty day moving average price of $4.59 and a 200-day moving average price of $4.51. Raia Drogasil has a 12-month low of $2.17 and a 12-month high of $5.34.
Analysts Set New Price Targets
Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Read More
- Five stocks we like better than Raia Drogasil
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
